Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.

Authors :: Ruzzo A
Graziano F
Galli F
Galli F
Rulli E
Lonardi S
Ronzoni M
Massidda B
Zagonel V
Pella N
Mucciarini C
Labianca R
Ionta MT
Bagaloni I
Veltri E
Sozzi P
Barni S
Ricci V
Foltran L
Nicolini M
Biondi E
Bramati A
Turci D
Lazzarelli S
Verusio C
Bergamo F
Sobrero A
Frontini L
Magnani M
Source :: Scientific reports [Sci Rep] 2020 Jan 31; Vol. 10 (1), pp. 1918. Date of Electronic Publication: 2020 Jan 31.
Publication Year :: 2020
Abstract: An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Full Text Access

Tools